12:17 PM EST - Trillium Therapeutics Inc. : Reported financial results for the six months ended June 30, 2019. The working capital balance was $31.4 million, compared to $34.2 million at December 31, 2018. Net loss for the six months of $17.2 million was lower than the loss of $20.9 million for the six months ended June 30, 2018. Trillium Therapeutics Inc.
shares T.TRIL are trading down $0.025 at $0.38.
